Navigation Links
Poniard Pharmaceuticals Provides Year-End Clinical Update at 2007 Lazard Capital Markets Healthcare Conference
Date:11/27/2007

of metastatic HRPC in combination with full-dose docetaxel (Taxotere(R)) and prednisone. The Company continues to expect to fully enroll this trial by the end of 2007. The Company expects to present clinical data from the Phase 1 and Phase 2 HRPC trials at scientific meetings throughout 2008.

Phase 1 Oral Picoplatin Trial:

An oral formulation of picoplatin is being evaluated in an ongoing Phase 1 clinical trial in solid tumors. Poniard has completed the planned enrollment of the planned dose levels and has expanded the enrollment to include additional testing of various dose levels to provide additional data to support further development. This Phase 1 study compares the bioavailability, pharmacokinetics, pharmacodynamics and safety of picoplatin administered orally with picoplatin administered intravenously in patients with advanced solid tumor malignancies. The company plans to present data from the Phase 1 trial at scientific meetings in 2008.

Lazard Presentation and Webcast Information

Dr. McMahon will present at the Lazard Capital Markets Fourth Annual Healthcare Conference today at 9:30 a.m. Eastern Time at The New York Palace Hotel. A live audio webcast of the presentation will be available for 10 business days on the "Events" page of the "News & Events" section of the Company's website at http://www.poniard.com.

About Picoplatin

Picoplatin is a new generation platinum chemotherapy agent with the potential to become a platform product addressing multiple indications, combinations and formulations. Picoplatin has an improved safety profile compared to existing platinum-based chemotherapeutics and was designed to overcome platinum resistance. Picoplatin has been evaluated in more than 750 patients and has demonstrated activity in multiple indications with no evidence of significant kidney, nerve toxicity and hearing loss. The Company is evaluating picoplatin in four dif
'/>"/>

SOURCE Poniard Pharmaceuticals
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
2. Poniard Pharmaceuticals Announces Updated Results of Picoplatin Phase 2 Trial Demonstrating Survival Benefit in Small Cell Lung Cancer Patients
3. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
4. Poniard Pharmaceuticals Initiates Randomized Phase 2 Trial of Picoplatin for First-Line Treatment of Metastatic Colorectal Cancer
5. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
8. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
9. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... 27, 2015 According to a new market ... Seating, Universal, Standing, Bariatric ), Material (Nylon, Padded, Canvas), Usage Type ... published by MarketsandMarkets, the Medical Lifting Sling Market is poised to ... 2015, at a CAGR of 11.4 % from 2015 to 2020. ... rket data T ables and 65 ...
(Date:8/27/2015)... Pa. , Aug. 27, 2015  Now that ... the Da Vinci S™ surgical robot, hospitals with robotic ... plans. They also need to see where they stand ... on the right patients? Have they adopted best practices ... surgery program in the future? ECRI Institute, ...
(Date:8/27/2015)... 2015   Proxsys Rx, the nation,s ... expanding its population health management services with ... care program for hospitals and health systems. ... with technology systems and pharmacy support services ... been mandated by Center for Medicare and ...
Breaking Medicine Technology:Medical Lifting Sling Market Worth USD 706.0 Million by 2020 2Medical Lifting Sling Market Worth USD 706.0 Million by 2020 3Medical Lifting Sling Market Worth USD 706.0 Million by 2020 4ECRI Institute's New Robotic Surgery Service Helps Hospitals Brace for Change 2ECRI Institute's New Robotic Surgery Service Helps Hospitals Brace for Change 3Rx Care Management by Proxsys Rx - Transition of Care Technology Helps Prevent Hospital Medication Errors 2
... AirPal ®, a leading innovator and supplier ... the expansion of its line of air-activated transfer pads ... announcement marks the launch of an entire new series ... President AirPal, Inc.  "Among other functions, these exciting new ...
... recently merged with World Wide Relics (OTC Bulletin Board: ... its name to China PharmaHub Corp, is proud to ... Yongkon Pharmacy Co. Ltd., ("Yongkon"), a pharmaceutical company based ... 2600 hospitals in China.  PharmaHub was authorized by Yongkon ...
Cached Medicine Technology:AirPal Expands Line of Air-Activated Transfer Pads to Include Multi-Purpose Patient Positioning Functionality 2China PharmaHub Signs Agreement with Chengdu Yongkon Pharmacy 2China PharmaHub Signs Agreement with Chengdu Yongkon Pharmacy 3
(Date:8/28/2015)... MO (PRWEB) , ... August 28, 2015 , ... ... testosterone lawsuits now consolidated as MDL 2545, Testosterone Replacement Therapy Products ... a cap on the number of custodial files the PSC may receive for ...
(Date:8/28/2015)... ... ... Super-Sod launched their new website this summer. The new user-friendly ... the responsive web design. Website users will now have an improved browsing experience on ... sod, sign-up for the monthly turf-tips email, and find a local Super-Sod store all ...
(Date:8/28/2015)... ... 2015 , ... The Wilson and Juanita Mann Health Center ... a patient’s quality of life through early diagnosis and treatment. The focus is ... HIV/AIDS, STDs, and others. A Women’s, Infants & Children (WIC) clinic also provides ...
(Date:8/27/2015)... ... August 28, 2015 , ... Grace Bay Beach has been recognized ... to an already impressive list of accolades for the Turks and Caicos so far ... beach in the world by TripAdvisor, the world's leading authority on travel. , ...
(Date:8/27/2015)... ... ... Mesa Community College graduate, Andrew Sypher (Mesa), is one of 10 ... and engagement, to receive a Phi Theta Kappa 2015 Hites Transfer Scholarship, to assist ... a $7,500 scholarship to assist in his goal of becoming a foreign diplomat with ...
Breaking Medicine News(10 mins):Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 2Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 3Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 4Health News:Health Clinic Opening and Public Art Unveiling 2Health News:Grace Bay Beach Acknowledged as a Top Caribbean Beach for Weddings 2Health News:Mesa Community College Graduate Andrew Sypher Receives Hites Transfer Scholarship 2Health News:Mesa Community College Graduate Andrew Sypher Receives Hites Transfer Scholarship 3
... show a persistent cellular memory in the brain,s reward ... drug, while their involuntary counterparts had no such memory, ... University of California, San Francisco. , The researchers conclude ... enough to cause long-lasting cellular memories in the brain,s ...
... 30th,Representative Jose Serrano (D-NY) introduced the Community AIDS ... will remove all legal,barriers to States and local ... prevention of diseases directly on syringe exchange.,Syringe exchanges ... intravenous,drug users obtain clean syringes in order to ...
... Toronto Stock Exchange Symbol: CYT, MONTREAL, ... the global leader in cryotherapy products to treat ... CEO of,CryoCath, will present a corporate update at ... will take place Wednesday, August,6th at 8:30 a.m. ...
... athletes gear up to travel to China for the ... respiratory illnesses and dog bites, according to report by ... the Centers for Disease Control and Prevention (CDC) and ... can lead to human rabies. The report finds that ...
... Presented at ICAD 2008 Highlight Significant Improvement in Cognitive Performance ... , ... Chicago, IL (PRWEB) July ... FRX) presented today positive Phase III data of a once-daily ...
... July 30 A minnow has taken on the,giants ... Orgasm Day to,promote the health and sex benefits of ... Ltd, the Orgasm Survey ( http://www.orgasmsurvey.co.uk ),has become a ... But the real story behind the survey has nothing ...
Cached Medicine News:Health News:Cocaine addiction linked to voluntary drug use and cellular memory, UCSF study shows 2Health News:AIDS Action Applauds Introduction of a New Bill Allowing Federal Funds to Support Syringe Exchange Programs 2Health News:AIDS Action Applauds Introduction of a New Bill Allowing Federal Funds to Support Syringe Exchange Programs 3Health News:AIDS Action Applauds Introduction of a New Bill Allowing Federal Funds to Support Syringe Exchange Programs 4Health News:AIDS Action Applauds Introduction of a New Bill Allowing Federal Funds to Support Syringe Exchange Programs 5Health News:AIDS Action Applauds Introduction of a New Bill Allowing Federal Funds to Support Syringe Exchange Programs 6Health News:AIDS Action Applauds Introduction of a New Bill Allowing Federal Funds to Support Syringe Exchange Programs 7Health News:AIDS Action Applauds Introduction of a New Bill Allowing Federal Funds to Support Syringe Exchange Programs 8Health News:AIDS Action Applauds Introduction of a New Bill Allowing Federal Funds to Support Syringe Exchange Programs 9Health News:Respiratory illnesses and dog bites a concern for travelers to China for 2008 Olympics 2Health News:New Data Highlights Positive Results of Namenda (Memantine HCl) Once-Daily Extended-Release Formulation 2Health News:New Data Highlights Positive Results of Namenda (Memantine HCl) Once-Daily Extended-Release Formulation 3Health News:New Data Highlights Positive Results of Namenda (Memantine HCl) Once-Daily Extended-Release Formulation 4Health News:National Orgasm Day 31 July 2008 - Women's Health Campaign Reaches Climax 2
Eyeglass Loupe 3x-5x made with precision optical glass. Ideal for any detail work....
... Specifically designed for computer operators ... may be placed at different heights ... computer screen. Card is printed two ... and green and uses two type ...
Near PT test card/child recog/ playing cards 5 1/2" X 8"....
Near PT test card/4 1/2 to 12 PT in spanish & french /5 1/2" X 8....
Medicine Products: